Parecoxib for postoperative pain after minor gynaecological surgery

Phase 4

Completed

• Conditions: Pain following dilatation and currettage and/or hystersocopy; Reproductive Health and Childbirth - Pain management

• Registration Number: ACTRN12606000480583
• Lead Sponsor: individual (Kate Luscombe)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-11-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

American Society of Anesthesiologists (ASA) physical status classifiaction I or II Undergoing dilatation and curettage +/- hysteroscopy

Exclusion Criteria

Renal dysfunction Hypertension History of sulphonamide allergy Unsuitable for general anaesthesia with maintenance by inhalational agent Use of suxamethonium Preoperative use of NSAID or opiate analgesics

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
0 - 10 cm numerical rating scale pain score with movement[At one hour postoperatively]

Secondary Outcome Measures

Name	Time	Method
Pain score [at rest 1 hour postop];Pain score [at 2 and 24 hours postop];Time to first use of postoperative intravenous fentanyl analgesia[as occurs up until discharge from hospital];Time to first use of postoperative oral tramadol analgesia[as occurs until discharge from hospital];Total dose of intravenous fentanyl [at discharge from recovery room];Total dose of oral tramadol [at 24 h postop];Nausea/vomiting incidence [at 24 h postop];Headache incidence [at 24 h postop];Quality of recovery (QoR)score [at 24 hour postop ];Health outcomes recovery (H.O.R) questionnaire score [at 24 hour postop ];Satisfaction score [at 24 h postop]